Are Zota Health Care Ltd latest results good or bad?

Feb 05 2026 07:32 PM IST
share
Share Via
Zota Health Care Ltd's latest results show strong revenue growth of 98.21% year-on-year, but the company faces significant challenges with a net loss of ₹29.50 crores and deteriorating profitability metrics, raising concerns about its long-term sustainability.
Zota Health Care Ltd's latest financial results for Q3 FY26 reveal a complex scenario characterized by significant revenue growth alongside deepening losses. The company reported net sales of ₹142.95 crores, reflecting a robust year-on-year growth of 98.21% compared to ₹72.12 crores in Q3 FY25. This growth trajectory has been consistent over the last four quarters, indicating strong market traction and an aggressive expansion strategy.
However, the profitability metrics present a stark contrast to the revenue achievements. The company recorded a net loss of ₹29.50 crores, which represents a substantial deterioration in profitability, with losses widening by 84.95% quarter-on-quarter and 57.92% year-on-year. The operating margin, excluding other income, fell to -0.31%, down from a positive 4.90% in the previous quarter, indicating severe operational challenges. Additionally, the profit after tax (PAT) margin contracted to -20.73%, further highlighting the company's struggle to convert sales growth into profit. The financial data also indicates that Zota Health Care's operational inefficiencies are exacerbated by rising costs, particularly in employee expenses, which surged significantly compared to revenue growth. This imbalance raises concerns about the sustainability of the company's growth strategy, as the cash flow statement reveals negative operating cash flow of ₹-49.00 crores for FY25, suggesting a troubling cash burn situation. In terms of valuation, Zota Health Care appears to be trading at a significant premium compared to its peers, with a price-to-book value ratio of 14.21 times. This elevated valuation, coupled with deteriorating fundamentals, has led to an adjustment in its evaluation, reflecting the market's cautious sentiment towards the company's future prospects. Overall, while Zota Health Care demonstrates impressive revenue growth, the accompanying financial challenges and operational inefficiencies create a complex picture that warrants careful consideration by stakeholders. The company must address its profitability crisis to restore investor confidence and ensure long-term sustainability.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Zota Health Care Ltd is Rated Sell by MarketsMOJO
Feb 01 2026 10:10 AM IST
share
Share Via
Why is Zota Health Care Ltd falling/rising?
Jan 28 2026 12:57 AM IST
share
Share Via
Zota Health Care Ltd is Rated Sell
Jan 21 2026 10:10 AM IST
share
Share Via
Zota Health Care Ltd is Rated Sell
Jan 10 2026 10:10 AM IST
share
Share Via
Zota Health Care Ltd is Rated Sell
Dec 30 2025 10:10 AM IST
share
Share Via